News

Home>News
News2020-07-17T11:41:26-04:00
Feb 82024

Halberd and Mississippi State University to Commence Stage II Advanced TBI Nasal Spray Testing

February 8th, 2024|Categories: Featured, Investor News, News, Press Releases|Tags: , , , |

Jackson Center, PA February 8, 2024 – Halberd Corporation’s (OTC-PINK: "HALB”) Traumatic Brain Injury (TBI) mitigating nasal spray testing protocols at Mississippi State University (MSU) were approved by the Institutional Animal Care and Use Committee. Dr. Russell Carr, the Primary Investigator, initiated preparations for this extension of the successful Phase #1 pilot test program, completed last year with demonstrably compelling results. The advanced program will launch promptly.  Numerous federal agencies expressed enthusiasm for the pursuit. ...

Feb 72024

Halberd’s Top Executives Join Forces with Athena GTX CEO Mark Darrah Unveiling 2024 Powerful Partnership Outlook on “The Street Reports Podcast”

February 7th, 2024|Categories: Investor News, News, Press Releases|Tags: , , , , |

JACKSON CENTER, PA February 6, 2024 -- Halberd Corporation’s (OTC: HALB) and Athena GTX’s executives interviewed on "The Street Reports," discuss the relationship between Halberd and Athena and why that relationship is going to advance Halberd’s breakthrough technologies toward government contracts. Listen here: https://thestreetreports.com/halb-ceo-william-hartman-cto-dr-mitchell-felder-and-ceo-of-athena-gtx-mark-darrah-discuss-company-partnership-and-optimistic-2024-on-the-street-reports-podcast-listen-now/ To get the latest on Halberd’s exciting developments, subscribe by submitting this form. (https://halberdcorporation.com/contact-us/). For more information please contact: William A. Hartman w.hartman@halberdcorporation.com support@halberdcorporation.com www.halberdcorporation.com Twitter:@HalberdC About Mississippi State University College ...

Jan 112024

Halberd Corporation 2023 Year-End CEO Update and 2024 Goals

January 11th, 2024|Categories: Featured, Investor News, News|Tags: , , , |

Jackson Center, PA, January 11, 2024 -- Halberd Corporation (OTC: HALB) made significant advances in its technology development and accomplished major business goals during the second half of 2023. 2023 ACHIEVEMENTS Halberd received from the CDC two sets of antibiotic resistant bacteria and fungi (a total of 60 samples) on which to test its proprietary laser eradication methodology. Testing at Youngstown State University (YSU) successfully eradicated every sample of the various strains of E. coli, ...

Jan 92024

Halberd Corp. Signs Significant Revenue Sharing Agreement with Athena GTX

January 9th, 2024|Categories: Featured, Investor News, Press Releases|Tags: , , , |

Athena will employ its successful history of securing government contracts, spearheading such initiatives Jackson Center, PA January 9, 2024 – Halberd Corporation (OTC-PINK: "HALB”) is thrilled to declare the formalization of a profitable revenue-sharing accord with Athena GTX, Inc., of Johnston, Iowa, (www.athenagtx.com).  Athena GTX is a private enterprise specializing in providing medical care solutions tailored for first responders in both civilian and government sectors. Athena’s 20+ year history of innovative research and development funding ...

Dec 132023

Halberd Corporation Signs Multi-Faceted Agreement with CrodenHealth.com

December 13th, 2023|Categories: Featured, Investor News, News, Press Releases|Tags: , , , |

Peter Croden, CrodenHealth Chairman, previously executive with Pharmacia & Upjohn (Pfizer), Upjohn Canada, Upjohn Global Animal Health, NephRx, and Parnell Pharmaceuticals Holdings, Ltd. Endeavors to move Halberd forward Jackson Center, PA December 13, 2023 – Halberd Corporation (OTC-PINK: "HALB”) and CrodenHealth.com of Canada agree to produce, market, sell and distribute Halberd’s patented low dose naltrexone combo product(s) worldwide.  The agreement also allows CrodenHealth.com right of first refusal regarding similar rights to future products in Halberd’s ...

Nov 152023

Halberd Corporation Plans to Extend Research Partnership with Mississippi State University

November 15th, 2023|Categories: Featured, Investor News, News, Press Releases|Tags: , , , , , , |

MSU Research for Halberd to Transcend the TBI Nasal Spray Jackson Center, PA November 15, 2023 – Halberd Corporation (OTC-PINK: "HALB”) is in talks with Mississippi State University (MSU) to extend its original six-month research arrangement by an additional two years, encompassing yet-to-be defined projects. This decision stems from MSU's exceptional performance in the recent TBI Nasal Spray project, as well as the proficiency, capabilities, efficiency, and professionalism exhibited by the MSU team. Notably, the ...

Go to Top